BioWorld MedTech

Aug. 11, 2011

Med-tech faces uncertainty in healthcare landscape

ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily) Read More

Washington roundup: CMS eyes wider indication for extracorporeal photopheresis

International report: First Latin American use of Medtronic Symplicity performed

New ventures: Misonix now enters surgical wound debridement market

Deals roundup: Despite buyout rejection, Alere acquires more Axis-Shield stock

Financings roundup: Masimo's board authorizes repurchase of up to 3M shares

Agreements/contracts: TrovaGene stops Sequenom, regains transrenal tech rights

Grants roundup: ApoCell awarded $2.9M contract for 12 alpha prototype units

HIT roundup: Boston Sci launches NLI for spinal cord stimulation

Med-Tech Notes

People in the News

Product Briefs

Abbott Vascular gets FDA approval for RX Herculink

MDD's Ortho Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...